Conditioning Regimens
|
The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity
|
915
|
M Hassan, P Ljungman, O Ringdén, Z Hassan, G Öberg, C Nilsson, A Békassy, M Bielenstein, M Abdel-Rehim, S Georén & L Astner
|
Abstract Full Article PDF
|
 |
An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for leukemia or genetic disease
|
925
|
AM Bolinger, AB Zangwill, JT Slattery, D Glidden, K DeSantes, L Heyn, LJ Risler, B Bostrom & MJ Cowan
|
Abstract Full Article PDF
|
 |
|
Progenitor Cell Mobilisation
|
Single vs twice daily G-CSF dose for peripheral blood stem cells harvest in normal donors and children with non-malignant diseases
|
931
|
V Lee, CK Li, MMK Shing, KW Chik, K Li, KS Tsang, DC Zhao, DH Lai, A Wong & PMP Yuen
|
Abstract Full Article PDF
|
 |
|
Neuroblasstoma
|
Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma
|
937
|
D Valteau-Couanet, E Benhamou, G Vassal, F Stambouli, V Lapierre, D Couanet, J Lumbroso & O Hartmann
|
Abstract Full Article PDF
|
 |
|
Acute Leukemia
|
Poor outcome in children with refractory/relapsed leukemia undergoing bone marrow transplantation with mismatched family member donors
|
943
|
FD Goldman, SL Rumelhart, P DeAlacron, MD Holida, NF Lee, J Miller, M Trigg & R Giller
|
Abstract Full Article PDF
|
 |
|
Myeloma
|
Acute lymphoblastic leukaemia-type intensive chemotherapy to eliminate minimal residual disease after high-dose melphalan and autologous transplantation in multiple myeloma a phase I/II feasibility and tolerance study of 17 patients
|
949
|
R Powles, B Sirohi, S Kulkarni, N Bhagwati, R Saso, N Raje, C Horton, S Singhal, J Mehta & J Treleaven
|
Abstract Full Article PDF
|
 |
|
Non-Hodgkins Lymphoma
|
Prognostic factors for the clinical outcome of patients with follicular lymphoma following high-dose therapy and peripheral blood stem cell transplantation (PBSCT)
|
957
|
MT Voso, S Martin, S Hohaus, A Abdallah, RF Schlenk, AD Ho & R Haas
|
Abstract Full Article PDF
|
 |
|
Graft Versus Host Disease
|
New oral formulation of cyclosporin A (Neoral) pharmacokinetics in allogeneic bone marrow transplant recipients
|
965
|
N Parquet, O Reigneau, H Humbert, M Guignard, P Ribaud, G Socié, A Devergie, H Espérou & E Gluckman
|
Abstract Full Article PDF
|
 |
|
Infections Post Transplant
|
Disseminated toxoplasmosis following T cell-depleted related and unrelated bone marrow transplantation
|
969
|
TN Small, L Leung, J Stiles, TE Kiehn, SA Malak, RJ O'Reilly & K Sepkowitz
|
Abstract Full Article PDF
|
 |
Bronchoalveolar lavage in the diagnosis of pulmonary complications of bone marrow transplant patients
|
975
|
AJ Huaringa, FJ Leyva, J Signes-Costa, RC Morice, I Raad, AA Darwish & RE Champlin
|
Abstract Full Article PDF
|
 |
|
Post Transplant Complications
|
Encouraging results in the treatment of haemorrhagic cystitis with estrogen report of 10 cases and review of the literature
|
981
|
R Ordemann, R Naumann, G Geissler, M Bornhauser, U Schuler & G Ehninger
|
Abstract Full Article PDF
|
 |
Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation
|
987
|
D Azoulay, D Castaing, A Lemoine, GM Hargreaves & H Bismuth
|
Abstract Full Article PDF
|
 |
N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation
|
993
|
O Ringdén, M Remberger, S Lehmann, P Hentschke, J Mattsson, S Klaesson & J Aschan
|
Abstract Full Article PDF
|
 |
|
Economic Study
|
Cost-effectiveness of CD34+ dose in peripheral blood progenitor cell transplantation for non-Hodgkin's lymphoma patients: a single centre study
|
997
|
S Limat, MC Woronoff-Lemsi, E Deconinck, E Racadot, M Jacquet, P Herve & JY Cahn
|
Abstract Full Article PDF
|
 |
|
Case Reports
|
Acute abdomen without cutaneous signs of varicella zoster virus infection as a late complication of allogeneic bone marrow transplantation: importance of empiric therapy with acyclovir
|
1003
|
T Yagi, T Karasuno, T Hasegawa, M Yasumi, S Kawamoto, M Murakami, N Uosima, H Nakamura, A Hiraoka & T Masaoka
|
Abstract Full Article PDF
|
 |
Dental manifestations in severe combined immunodeficiency following bone marrow transplantation
|
1007
|
BOI Cole, RR Welbury, E Bond & M Abinun
|
Abstract Full Article PDF
|
 |
Radiation-induced bone sarcoma following total body irradiation: role of additional radiation on localized areas
|
1011
|
YM Kirova, H Rafi, M-C Voisin, C Rieux, M Kuentz, S Le Mouel, E Levy & C Cordonnier
|
Abstract Full Article PDF
|
 |
Severe hypophosphatemia during hematopoietic reconstitution after allogeneic peripheral blood stem cell transplantation
|
1015
|
M Steiner, B Steiner, S Wilhelm, M Freund & P Schuff-Werner
|
Abstract Full Article PDF
|
 |
 |
 |